Rebecca Frise

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

SARS-CoV-2 variants retain high airborne transmissibility by different strategies.

SARS-CoV-2 variants retain high airborne transmissibility by different strategies.

Journal: Npj viruses

Published: February 12, 2025

Omicron breakthrough infections in vaccinated or previously infected hamsters.

Omicron breakthrough infections in vaccinated or previously infected hamsters.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: October 30, 2023

Evaluation of a human mucosal tissue explant model for SARS-CoV-2 replication.

Evaluation of a human mucosal tissue explant model for SARS-CoV-2 replication.

Journal: PloS one

Published: May 24, 2023

Mammalian ANP32A and ANP32B Proteins Drive Differential Polymerase Adaptations in Avian Influenza Virus.

Mammalian ANP32A and ANP32B Proteins Drive Differential Polymerase Adaptations in Avian Influenza Virus.

Journal: Journal of virology

Published: April 19, 2023

Levels of Influenza A Virus Defective Viral Genomes Determine Pathogenesis in the BALB/c Mouse Model.

Levels of Influenza A Virus Defective Viral Genomes Determine Pathogenesis in the BALB/c Mouse Model.

Journal: Journal of virology

Published: October 13, 2022

Polymer formulated self-amplifying RNA vaccine is partially protective against influenza virus infection in ferrets.

Polymer formulated self-amplifying RNA vaccine is partially protective against influenza virus infection in ferrets.

Journal: Oxford open immunology

Published: January 04, 2022

An Influenza A virus can evolve to use human ANP32E through altering polymerase dimerization.

An Influenza A virus can evolve to use human ANP32E through altering polymerase dimerization.

Journal: Nature communications

Published: December 03, 2021

A self-amplifying RNA vaccine protects against SARS-CoV-2 (D614G) and Alpha variant of concern (B.1.1.7) in a transmission-challenge hamster model.

A self-amplifying RNA vaccine protects against SARS-CoV-2 (D614G) and Alpha variant of concern (B.1.1.7) in a transmission-challenge hamster model.

Journal: Vaccine

Published: December 01, 2021

Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults.

Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults.

Journal: Nature medicine

Published: November 28, 2021

Distinct airway epithelial immune responses after infection with SARS-CoV-2 compared to H1N1.

Distinct airway epithelial immune responses after infection with SARS-CoV-2 compared to H1N1.

Journal: Mucosal immunology

Published: November 26, 2021

A natural variant in ANP32B impairs influenza virus replication in human cells.

A natural variant in ANP32B impairs influenza virus replication in human cells.

Journal: The Journal of general virology

Published: September 15, 2021

Mutations that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway.

Mutations that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway.

Journal: Cell reports

Published: September 01, 2021

Showing 1-12 of 26

Last Updated: 09/26/2026